Australia’s Senate is launching a formal inquiry into issues involving patient access to medical cannabis. Limited access to medical marijuana has restricted the accessible domestic market in Australia. Improvements to availability pathways and regulatory overlap...
An industry group representing Canada's biggest cannabis companies is appealing to Prime Minister Justin Trudeau to help address some of the industry’s most persistent challenges. In a letter sent to Trudeau on Nov. 9 and made public Thursday night, the Cannabis...
Aurora Cannabis is ceasing construction at its large second-phase facility in Denmark and deferring most of the final construction at its Aurora Sun facility in Medicine Hat, Alberta, as the company's losses widened substantially in the quarter. The moves would save...
British Columbia’s plan to slap a 20% tax on retail sales of cannabis vaporizer products imperils the success of legalization, a marijuana industry group said.
New Brunswick’s government is getting out of the cannabis retail business, presenting an opportunity for the private sector.
Canopy Growth’s net revenue plunged 15% compared to the previous quarter, a development the Ontario-based company attributed to a “challenging” period in the Canadian cannabis sector.
Australia’s westernmost state is making it easier for patients to access medical cannabis. Western Australia said it will allow general practitioners to prescribe medical marijuana without the need for referral to a specialist, bringing the state in line with other...
British Columbia-based cannabis producer Tilray reported third-quarter revenue of $51.1 million (CA$67.8 million), a 408% jump from the same period a year earlier. Tilray also booked an 11% improvement from the second quarter's $46 million, in line with consensus...
Canada’s securities watchdog is warning the nation's cannabis businesses of "deficient" corporate governance disclosures and urging them to address concerns related to potential conflicts of interest. The Canadian Securities Administrators (CSA) issued a notice...
Ontario-based Cronos Group reported quarterly revenue of 12.7 million Canadian dollars ($9.6 million), an improvement over the previous quarter’s CA$10.2 million but slightly lower than consensus estimates. The cannabinoid company’s adjusted EBITDA loss widened...
Citing Ontario’s slow cannabis retail build-out, Organigram Holdings issued revenue guidance for expected fourth-quarter net revenue of 16.3 million Canadian dollars ($12.3 million), a substantial decline from the previous quarter’s CA$24.8 million. Analysts had...
Jamaica plans to overhaul the interim regulations governing legal marijuana businesses and create a national road map to support the development of the island’s regulated industry. The support could help businesses overcome obstacles hindering the sector's growth,...
